Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Cognition and Behavior

Inhibition of ASIC1a Improves Behavioral Recovery after Stroke

Ariel Armstrong, Tao Yang, Tiandong Leng and Zhi-Gang Xiong
eNeuro 17 January 2024, 11 (2) ENEURO.0341-23.2023; https://doi.org/10.1523/ENEURO.0341-23.2023
Ariel Armstrong
Department of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ariel Armstrong
Tao Yang
Department of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiandong Leng
Department of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi-Gang Xiong
Department of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    ASIC1a deletion does not impact mortality or weight after MCAO. a, ASIC1a+/+ and ASIC1a−/− mice did not significantly differ in survival for up to 28 d after MCAO. Survival data are presented as percentage surviving and analyzed by log rank test. b, ASIC1a+/+ and ASIC1a−/− mice also did not have significant differences in weight changes for up to 28 d after MCAO. Weight data are presented as mean ± SEM and analyzed by ANOVA (n = 9–11 for each group). The asterisks represent the significant changes in weight as compared with baseline measurement. *p < 0.05, **p < 0.01, ***p < 0.001.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Protective effect of ASIC1a knock-out on infarct volume after MCAO. a, Twenty-four hours after 30 min MCAO, mice were killed, and infarct volumes were determined using TTC staining. b, Knock-out of ASIC1a significantly reduced brain infarct volume. Data are presented as mean ± SEM and analyzed by t test (n = 4–5 for each group). *p < 0.05 when compared with ASIC1a+/+.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Knock-out of ASIC1a accelerates neurological deficit recovery. Neurological scoring was done prior to MCAO for baseline measurement and at the specified timepoints post-MCAO. Both ASIC1a+/+ and ASIC1a−/− mice had significant focal deficits over a 28 d period following MCAO. a, The focal deficit of ASIC1a−/− mice significantly improved from day 1 deficit a week earlier than ASIC1a+/+ mice. b, ASIC1a−/− mice had general deficits for fewer days and significantly improved from day 1 deficit 14 d earlier than ASIC1a+/+ mice. Data are presented as mean ± SEM and analyzed by two-way ANOVA (n = 11–13 for each group). The asterisks represent the significant differences as compared with day 0 measurement. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. The pound signs represent the significant differences as compared with day 1 measurement. #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Knock-out of ASIC1a improved mobility recovery but not sidedness bias after stroke. a, Representative visualization of the open field test. b, Both ASIC1a+/+ and ASIC1a−/− mice had reduced mobility after MCAO. Only ASIC1a−/− mice significantly recovered mobility. c, Both ASIC1a+/+ and ASIC1a−/− mice had significantly right-sidedness bias after MCAO and neither group significantly recovered within 28 d. Data are presented as mean ± SEM and analyzed by two-way ANOVA (open field n = 13–18 for each group, corner n = 7–11 for each group). The asterisks represent the significant differences as compared with baseline measurement. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. The pound signs represent the significant differences as compared with first day of measurement after MCAO. #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Protective effect of ASIC1a inhibition on infarct volume after focal cerebral ischemia. a, Representative images of TTC stained brains 24 h after 30 min MCAO. b, PcTX1-treated mice had a significantly reduced infarct volume when compared with vehicle mice. Data are presented as mean ± SEM and analyzed by t test (n = 5 for each group). *p < 0.05 when compared with vehicle.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Acute inhibition of ASIC1a improves neurological deficit recovery. Neurological scoring was done prior to MCAO for baseline measurement and at the specified timepoints post-MCAO using the previously described stroke scale. a, PcTX1 mice have significantly increased focal deficits for the first 3 d, and vehicle mice had significantly increased deficits for 7 d post-MCAO. b, PcTX1 mice had significantly increased general sickness on days 1, 3, and 5 post-MCAO and significantly recovered from that increase on day 21 post-MCAO. Vehicle mice had significantly increased general sickness on all days up to 7 d post-MCAO and significantly recovered from that increase on day 21 post-MCAO. Data are presented as mean ± SEM and analyzed by two-way ANOVA (n = 9–11 for each group). The asterisks represent the significant differences as compared with baseline measurement *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. The pound signs represent the significant differences as compared with day 1 measurement #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001. The crosses represent the significant differences as compared with day 5 measurement +p < 0.05, ++p < 0.01, +++p < 0.001, ++++p < 0.0001.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Acute inhibition of ASIC1a improved mobility recovery and sidedness bias after stroke. a, Representative visualization of the open field test. (b) Vehicle mice had reduced mobility for all days post-MCAO and did not significantly recover within 28 d post-MCAO. PcTX1 mice only had significantly reduced mobility on day 14 post-MCAO. c, Vehicle mice had severe right-sidedness bias on day 5 post-MCAO and significantly recovered by day 28 post-MCAO. PcTX1 mice did not have a significant increase in sidedness bias. Data are presented as mean ± SEM and analyzed by two-way ANOVA (n = 11–9 for each group). The asterisks represent the significant differences as compared with baseline measurement. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. The pound signs represent significant differences as compared with day 1 measurement. #<≤0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001.

Back to top

In this issue

eneuro: 11 (2)
eNeuro
Vol. 11, Issue 2
February 2024
  • Table of Contents
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of ASIC1a Improves Behavioral Recovery after Stroke
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Inhibition of ASIC1a Improves Behavioral Recovery after Stroke
Ariel Armstrong, Tao Yang, Tiandong Leng, Zhi-Gang Xiong
eNeuro 17 January 2024, 11 (2) ENEURO.0341-23.2023; DOI: 10.1523/ENEURO.0341-23.2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Inhibition of ASIC1a Improves Behavioral Recovery after Stroke
Ariel Armstrong, Tao Yang, Tiandong Leng, Zhi-Gang Xiong
eNeuro 17 January 2024, 11 (2) ENEURO.0341-23.2023; DOI: 10.1523/ENEURO.0341-23.2023
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • behavior
  • ischemia
  • recovery
  • stroke

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Aperiodicity in mouse CA1 and DG power spectra
  • Transcriptional Changes Fade Prior to Long-Term Memory for Sensitization of the Aplysia Siphon-Withdrawal Reflex.
  • Numbers of granule cells and GABAergic boutons are correlated in shrunken sclerotic hippocampi of sea lions with temporal lobe epilepsy
Show more Research Article: New Research

Cognition and Behavior

  • Is Social Media Use a Blessing or Cure for Motor Function and Skill Acquisition? An Opinion Paper
  • Transcriptional Changes Fade Prior to Long-Term Memory for Sensitization of the Aplysia Siphon-Withdrawal Reflex.
  • Short-Term Perceptual Training Modulates Neural Responses to Deepfake Speech but Does Not Improve Behavioral Discrimination
Show more Cognition and Behavior
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.